JUNE 2026 – Its first story on the subject was published a year ago this week, and since then nonprofit investigative news service ProPublica has deployed more than a dozen reporters to address regulation of generic drugs in the US. The bottom line from all that work: The marketplace of generic medications has lax oversight, leading to risks for consumers that have been widely ignored. ProPublica’s first story ran June 17, 2025, and continued through the year; in December the outfit released a database for anyone to learn where their generic drugs are manufactured. More stories appeared in the first half of this year. The scope of the project is rare in today’s resource-starved world of investigative journalism. Among the reporters who undertook the yearlong project: Debbie Cenziper, Megan Rose, Brandon Roberts, Ruth Talbot, Nick McMillan, Irena Hwang, and more who contributed from the Medill Investigative Lab. The series was a finalist for a 2025 Pulitzer Prize.